Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b

Detalles Bibliográficos
Autores principales: Hong, Sun In, Ryu, Byung-Han, Chong, Yong Pil, Lee, Seungjun, Kim, Sunjoo, Kim, Ho Cheol, Hong, Kyung-Wook, Bae, In-Gyu, Cho, Oh-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293467/
https://www.ncbi.nlm.nih.gov/pubmed/32544570
http://dx.doi.org/10.1016/j.ijantimicag.2020.106052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293467/
https://www.ncbi.nlm.nih.gov/pubmed/32544570
http://dx.doi.org/10.1016/j.ijantimicag.2020.106052

Ejemplares similares